Trial Profile
A phase I study of ISIS-GSK4Rx in healthy volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Aug 2023
Price :
$35
*
At a glance
- Drugs IONIS GSK4-LRx (Primary)
- Indications Eye disorders
- Focus Adverse reactions
- 28 Oct 2015 New trial record